Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.24 USD | +0.81% | -2.36% | +22.77% |
Mar. 04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 04 | Passage Bio, Inc. Appoints Kathleen Borthwick as Chief Financial Officer | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 75.78M |
---|---|---|---|---|---|
Net income 2024 * | -76M | Net income 2025 * | -89M | EV / Sales 2024 * | - |
Net cash position 2024 * | 51.6M | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.01
x | P/E ratio 2025 * |
-1.27
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.68% |
Latest transcript on Passage Bio, Inc.
1 day | +0.81% | ||
Current month | -8.15% | ||
1 month | -10.79% | ||
3 months | +40.75% | ||
6 months | +85.35% | ||
Current year | +22.77% |
Managers | Title | Age | Since |
---|---|---|---|
William Chou
CEO | Chief Executive Officer | 51 | 22-10-09 |
James M. Wilson
FOU | Founder | - | 17-06-30 |
Director of Finance/CFO | 48 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Maxine Gowen
CHM | Chairman | 66 | 21-02-17 |
Michael Kamarck
BRD | Director/Board Member | 73 | 22-07-01 |
Saqib Islam
BRD | Director/Board Member | 54 | 19-03-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 1.24 | +0.81% | 39,304 |
24-04-23 | 1.23 | +7.89% | 53,690 |
24-04-22 | 1.14 | -0.87% | 84,360 |
24-04-19 | 1.15 | -4.17% | 284,220 |
24-04-18 | 1.2 | -5.51% | 122,534 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.77% | 75.78M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- PASG Stock